Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umme Rumana

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Drugs|July 15, 2015
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer DrugsRichard Kones, Umme Rumana
Drugs|June 28, 2015
Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional TherapiesRichard Kones, Umme Rumana
Journal of Women'S Health (2002)|May 11, 2013
Dyslipidemia, risk factors, and the prevention of cardiovascular disease in womenRichard Kones, Umme Rumana
Annals of Medicine|December 13, 2016
Cardiometabolic diseases of civilization: history and maturation of an evolving global threat. An update and call to actionRichard Kones, Umme Rumana
Hospital Practice (1995)|February 26, 2014
Prevention of cardiovascular disease: updating the immensity of the challenge and the role of risk factorsRichard Kones, Umme Rumana
Hospital Practice (1995)|September 26, 2014
Cardiovascular prevention: components, levels, early origins, and metricsRichard Kones, Umme Rumana
Cardiology Clinics|August 6, 2014
Stable ischemic heart diseaseRichard Kones, Umme Rumana
Heart Failure Clinics|November 17, 2015
Stable Ischemic Heart DiseaseRichard Kones, Umme Rumana
Postgraduate Medicine|January 3, 2018
Cultural primer for cardiometabolic health: health disparities, structural factors, community, pathways to improvement, and clinical applicationsRichard Kones, Umme Rumana
International Journal of Applied & Basic Medical Research|October 2, 2013
Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance?Richard Kones, Umme Rumana
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Drugs|July 15, 2015
Current Treatment of Dyslipidemia: Evolving Roles of Non-Statin and Newer DrugsRichard Kones, Umme Rumana
Drugs|June 28, 2015
Current Treatment of Dyslipidemia: A New Paradigm for Statin Drug Use and the Need for Additional TherapiesRichard Kones, Umme Rumana
Journal of Women'S Health (2002)|May 11, 2013
Dyslipidemia, risk factors, and the prevention of cardiovascular disease in womenRichard Kones, Umme Rumana
Annals of Medicine|December 13, 2016
Cardiometabolic diseases of civilization: history and maturation of an evolving global threat. An update and call to actionRichard Kones, Umme Rumana
Hospital Practice (1995)|February 26, 2014
Prevention of cardiovascular disease: updating the immensity of the challenge and the role of risk factorsRichard Kones, Umme Rumana
Hospital Practice (1995)|September 26, 2014
Cardiovascular prevention: components, levels, early origins, and metricsRichard Kones, Umme Rumana
Cardiology Clinics|August 6, 2014
Stable ischemic heart diseaseRichard Kones, Umme Rumana
Heart Failure Clinics|November 17, 2015
Stable Ischemic Heart DiseaseRichard Kones, Umme Rumana
Postgraduate Medicine|January 3, 2018
Cultural primer for cardiometabolic health: health disparities, structural factors, community, pathways to improvement, and clinical applicationsRichard Kones, Umme Rumana
International Journal of Applied & Basic Medical Research|October 2, 2013
Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance?Richard Kones, Umme Rumana
Pageof 3